Robert F. Kennedy Jr. may soon be America's top pharmaceutical regulator. That is cause for concern in Seattle’s biotech ...

Want to stay on top of the science and politics driving biotech today? Sign up to get our biotech newsletter in your inbox.

Amgen executives and employees, local and state elected dignitaries, and an assortment of other local economic development ...

This December, Amgen received a second state incentive to expand its Holly Springs operations by adding another drug ...

In this opinion piece, Philipp Koellinger explores the changes required to level the playing field and accelerate both ...

Adding pamrevlumab to standard chemotherapy did not improve survival in patients with locally advanced pancreatic cancer ...

Harvard University launched LabXchange in January and the free science education platform acquired new resonance during the COVID-19 lockdowns that saw millions of students around the world move ...

The addition of sintilimab to neoadjuvant chemoradiotherapy achieved a 60% pathological complete response rate vs 47.3% with ...

A research team from Columbia Engineering and the Irving Institute for Cancer Dynamics made a pivotal discovery in the field ...

SAN FRANCISCO -- Older patients' survival in metastatic pancreatic cancer had a significant association with baseline ...

Every year, a health care think tank called the Lown Institute ranks the 10 worst examples of "profiteering and dysfunction" ...

A distinguished technology leader, Phanindra Kankanampati has established himself as an expert in procurement technology and ...